The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2, multicenter study of TILs treatment in advanced tumors with alterations in the SWI/SNF complex: The TILTS study.
 
Juan Martin-Liberal
Consulting or Advisory Role - Bristol-Myers Squibb; Highlight Therapeutics; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Elena Garralda
Employment - Next Oncology
Stock and Other Ownership Interests - 1TRIALSP
Consulting or Advisory Role - Anaveon; Boehringer Ingelheim; Ellipses Pharma; F-Star Therapeutics; Hengrui Therapeutics; Incyte; Janssen; MAB Discovery; Medscape; Roche; Sanofi; Seagen; Thermo Fisher Scientific
Speakers' Bureau - MSD; Novartis; Roche; Seagen; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Other Relationship - Adaptimmune (Inst); Affimed Therapeutics (Inst); Amgen (Inst); Anaveon (Inst); AstraZeneca (Inst); Bicycle Therapeutics (Inst); Bioinvent (Inst); BioNTech (Inst); Boehringer Ingelheim (Inst); Catalym (Inst); Cyclacel (Inst); CytomX Therapeutics (Inst); Cytovation (Inst); F-Star Beta Limited (Inst); F. Hoffmann LaRoche (Inst); Genentech (Inst); Genmab (Inst); HiFiBiO Therapeutics (Inst); Hutchison MediPharma (Inst); Imcheck Therapeutics (Inst); Immunocore (Inst); Incyte (Inst); Janssen-Cilag SA (Inst); MedImmune (Inst); Merck KGaA (Inst); Novartis (Inst); Peptomyc (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Replimune (Inst); Ribon Therapeutics (Inst); Roche (Inst); Ryvu Therapeutics (Inst); Seagen (Inst); SERVIER (Inst); Sotio (Inst); SQZ Biotech (Inst); Symphogen (Inst); T-Knife (Inst); Taiho Pharmaceutical (Inst)
 
Jesus Garcia Donas
Honoraria - AstraZeneca; BMS GmbH & Co. KG; GlaxoSmithKline; Incyte; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; GlaxoSmithKline; Incyte; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; BMS GmbH & Co. KG; GlaxoSmithKline; Incyte; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Hospitales HM
 
Juan Jose Soto
Travel, Accommodations, Expenses - Eisai; Pfizer; Seagen
 
Carles Codony
Employment - Pangaea Oncology (I)
 
Silvia Martín-Lluesma
No Relationships to Disclose
 
Susana Muñoz
Research Funding - AstraZeneca Spain (Inst); BiolineRX (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Oncostellae (Inst); Palobiofarma (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); The Lymphoma Academic Research Organization (Inst)
 
Vladimir Galvao
No Relationships to Disclose
 
M. Julia Lostes-Bardaji
No Relationships to Disclose
 
Marta Rotxés
No Relationships to Disclose
 
Sergio Querol
No Relationships to Disclose
 
Luciano Rodriguez
No Relationships to Disclose
 
Ainhoa Muñoz
No Relationships to Disclose
 
Rafael Moreno
No Relationships to Disclose
 
Xavier Garcia del Muro
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Deciphera; Eisai; GlaxoSmithKline; Ipsen; Merck; MSD; Pfizer; PharmaMar; Recordati; Roche
Speakers' Bureau - Astellas Pharma; Eisai; Pfizer; Recordati
Research Funding - AstraZeneca; Incyte
Travel, Accommodations, Expenses - Merck; Pfizer; Roche
 
Ramón Alemany
Employment - Theriva Biologics
Leadership - Theriva Biologics
Stock and Other Ownership Interests - Theriva Biologics
Honoraria - Theriva Biologics
Consulting or Advisory Role - Theriva Biologics
Research Funding - Theriva Biologics
Patents, Royalties, Other Intellectual Property - Theriva Biologics
Travel, Accommodations, Expenses - Theriva Biologics
 
Alena Gros
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; BioNTech; Instil Bio; Singula Bio
Speakers' Bureau - Genentech; Merck; Roche
Research Funding - Roche (Inst)
Patents, Royalties, Other Intellectual Property - Cellular Biomedicine Group; Geneius Biotechnology; Intellia Therapeutics; Intima Bioscience, Inc; Tailored Therapeutics
Travel, Accommodations, Expenses - Merck; Roche
 
Josep M. Piulats
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Clovis Oncology; IDEAYA Biosciences; Immunocore; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Immunocore; Incyte; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Pfizer/EMD Serono
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche